Patients with Recessive Dystrophic Epidermolysis Bullosa Develop Squamous-Cell Carcinoma Regardless of Type VII Collagen Expression
Open Access
- 1 October 2007
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 127 (10) , 2438-2444
- https://doi.org/10.1038/sj.jid.5700878
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Epidermolysis bullosa. II. Type VII collagen mutations and phenotype-genotype correlations in the dystrophic subtypesJournal of Medical Genetics, 2006
- Expanding the COL7A1 Mutation Database: Novel and Recurrent Mutations and Unusual Genotype – Phenotype Constellations in 41 Patients with Dystrophic Epidermolysis BullosaJournal of Investigative Dermatology, 2006
- Genetic tumor archeology: microdissection and genetic heterogeneity in squamous and basal cell carcinomaMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2005
- Type VII Collagen Is Required for Ras-Driven Human Epidermal TumorigenesisScience, 2005
- NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasiaNature, 2003
- Molecular basis of dystrophic epidermolysis bullosa: Mutations in the type VII collagen gene (COL7A1)Human Mutation, 1997
- Premature Termination Codons in the Type VII Collagen Gene (COL7A1) Underlie Severe, Mutilating Recessive Dystrophic Epidermolysis BullosaGenomics, 1994
- Type VII Collagen, Anchoring Fibrils, and Epidermolysis BullosaJournal of Investigative Dermatology, 1993
- Molecular biology and pathology of type VII collagen*Experimental Dermatology, 1992
- Antidesmosomal monoclonal antibody in the diagnosis of intracranial tumoursThe Journal of Pathology, 1987